A single-center, retrospective study assessing the effectiveness of Ospemifene plus fractional CO2 laser therapy in postmenopausal women with Dyspareunia and Vulvar pain
Latest Information Update: 23 Feb 2021
At a glance
- Drugs Ospemifene (Primary)
- Indications Dyspareunia; Vulvar vestibulitis; Vulvodynia
- Focus Therapeutic Use
Most Recent Events
- 23 Feb 2021 New trial record